ICD-10

ICD-10 code C22

You are here: Home > ICD-10-CM > C00-D49 > C00-C96 > C00-C75 > C15-C26

- ICD-10-CM
TABULAR LIST of DISEASES and INJURIES
- C00-D49
Neoplasms
- C00-C96
Malignant neoplasms
- C00-C75
Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue
- C15-C26
Malignant neoplasms of digestive organs

C22

Malignant neoplasm of liver and intrahepatic bile ducts

ICD-10 code C22 for Malignant neoplasm of liver and intrahepatic bile ducts

Excludes1: malignant neoplasm of biliary tract NOS (C24.9)
secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)
Use additional code to identify:
alcohol abuse and dependence (F10.-)
hepatitis B (B16.-, B18.0-B18.1)
hepatitis C (B17.1-, B18.2)
C22.0
Liver cell carcinoma
C22.1
Intrahepatic bile duct carcinoma
C22.2
Hepatoblastoma
C22.3
Angiosarcoma of liver
C22.4
Other sarcomas of liver
C22.7
Other specified carcinomas of liver
C22.8
Malignant neoplasm of liver, primary, unspecified as to type
C22.9
Malignant neoplasm of liver, not specified as primary or secondary
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us